NYSE:ABC

AmerisourceBergen Stock Forecast, Price & News

$106.80

+1.16 (+1.10 %)

(As of 01/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$104.53

Now: $106.80▼

$107.89

50-Day Range

$96.50

MA: $100.93▼

$110.13

52-Week Range

$72.06

Now: $106.80▼

$112.48

Volume3.23 million shs

Average Volume1.84 million shs

Market Capitalization$21.81 billion

P/E RatioN/A

Dividend Yield1.65%

Beta0.57

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

MarketRank^™

Overall MarketRank^™

1.87 out of 5 stars

2.3 Analyst's Opinion

Consensus Rating
AmerisourceBergen has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $110.00, AmerisourceBergen has a forecasted upside of 3.0% from its current price of $106.80.
Amount of Analyst Coverage
AmerisourceBergen has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.5 Community Rank

Outperform Votes
AmerisourceBergen has received 675 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
AmerisourceBergen has received 690 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
AmerisourceBergen has received 50.55% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote “Outperform” if you believe ABC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Yield
AmerisourceBergen pays a meaningful dividend of 1.65%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
AmerisourceBergen does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of AmerisourceBergen is 22.28%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 18.78% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AmerisourceBergen insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,342,330.00 in company stock.
Percentage Held by Insiders
Only 28.30% of the stock of AmerisourceBergen is held by insiders.
Percentage Held by Institutions
63.35% of the stock of AmerisourceBergen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for AmerisourceBergen are expected to grow by 11.81% in the coming year, from $8.38 to $9.37 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of AmerisourceBergen is -6.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of AmerisourceBergen is -6.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
AmerisourceBergen has a PEG Ratio of 1.11. PEG Ratios above 1 indicate that a company could be overvalued.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Drugs, proprietaries, & sundries

Sub-IndustryHealth Care Distributors

SectorMedical

Current SymbolNYSE:ABC

Previous Symbol

CUSIP03073E10

CIK1140859

Webwww.amerisourcebergen.com

Phone610-727-7000

Employees22,000

Debt

Debt-to-Equity Ratio0.91

Current Ratio0.98

Quick Ratio0.60

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E Ratio12.74

P/E Growth1.11

Sales & Book Value

Annual Sales$189.89 billion

Price / Sales0.11

Cash Flow$10.10 per share

Price / Cash Flow10.57

Book Value($4.11) per share

Price / Book-25.99

Profitability

EPS (Most Recent Fiscal Year)$7.90

Net Income$-3,408,720,000.00

Net Margins-1.80%

Return on Equity65.93%

Return on Assets3.91%

Miscellaneous

Outstanding Shares204,250,000

Market Cap$21.81 billion

Next Earnings Date2/4/2021 (Confirmed)

OptionableOptionable

$106.80

+1.16 (+1.10 %)

(As of 01/15/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

How has AmerisourceBergen's stock been impacted by Coronavirus (COVID-19)?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABC stock has increased by 25.7% and is now trading at $106.80.
View which stocks have been most impacted by COVID-19.

Is AmerisourceBergen a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than AmerisourceBergen?

Wall Street analysts have given AmerisourceBergen a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AmerisourceBergen wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for AmerisourceBergen.

How can I listen to AmerisourceBergen's earnings call?

AmerisourceBergen will be holding an earnings conference call on Thursday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) released its quarterly earnings data on Tuesday, November, 10th. The company reported $1.89 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.87 by $0.02. The company earned $49.24 billion during the quarter, compared to analyst estimates of $47.93 billion. AmerisourceBergen had a positive return on equity of 65.93% and a negative net margin of 1.80%. AmerisourceBergen's quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.61 EPS.
View AmerisourceBergen's earnings history.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen announced a quarterly dividend on Thursday, January 14th. Stockholders of record on Friday, February 12th will be given a dividend of $0.44 per share on Monday, March 1st. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend is Thursday, February 11th.
View AmerisourceBergen's dividend history.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.65%. The dividend payout ratio of AmerisourceBergen is 22.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 18.78% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY21 earnings guidance on Wednesday, January, 6th. The company provided earnings per share (EPS) guidance of $8.25-8.50 for the period, compared to the Thomson Reuters consensus estimate of $8.41.

What price target have analysts set for ABC?

9 brokers have issued 12-month target prices for AmerisourceBergen's stock. Their forecasts range from $88.00 to $130.00. On average, they expect AmerisourceBergen's stock price to reach $110.00 in the next twelve months. This suggests a possible upside of 3.0% from the stock's current price.
View analysts' price targets for AmerisourceBergen or view Wall Street analyst' top-rated stocks.

Who are some of AmerisourceBergen's key competitors?

Some companies that are related to AmerisourceBergen include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of ABC's competitors.

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), The Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), The Home Depot (HD) and Pfizer (PFE).

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:

Mr. Steven H. Collis, Chairman, Pres & CEO (Age 60, Pay $3.31M)
Mr. James F. Cleary Jr., Exec. VP & CFO (Age 58, Pay $1.35M)
Ms. Gina K. Clark, Exec. VP and Chief Communications & Admin. Officer (Age 64, Pay $1.07M)
Mr. John G. Chou, Exec. VP & Chief Legal Officer (Age 65, Pay $1.41M)
Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP & Group Pres (Age 54, Pay $1.44M)
Mr. Lazarus Krikorian, Sr. VP, Chief Accounting Officer & Corp. Controller (Age 56)
Bennett S. Murphy, Sr. VP of Investor Relations
Ms. Kathy H. Gaddes, Exec. VP & Chief Compliance Officer (Age 58)
Ms. Silvana Battaglia, Exec. VP & Chief HR Officer (Age 54)
Ms. Leslie E. Donato, Exec. VP & Chief Strategy Officer (Age 52)

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by many different institutional and retail investors. Top institutional shareholders include Wedge Capital Management L L P NC (0.14%), Hexavest Inc. (0.03%), Cypress Capital Group (0.02%), Huntington National Bank (0.02%), State of Alaska Department of Revenue (0.01%) and Bowling Portfolio Management LLC (0.01%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, James F Cleary Jr, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Richard W Gochnauer, Robert P Mauch and Steven H Collis.
View institutional ownership trends for AmerisourceBergen.

Which major investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Crossmark Global Holdings Inc., CX Institutional, Cypress Capital Group, Bowling Portfolio Management LLC, Donald L. Hagan LLC, State of Alaska Department of Revenue, and Granite Investment Advisors LLC. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen or view top insider-selling stocks.

Which major investors are buying AmerisourceBergen stock?

ABC stock was bought by a variety of institutional investors in the last quarter, including Prairiewood Capital LLC, Wedge Capital Management L L P NC, NuWave Investment Management LLC, IFM Investors Pty Ltd, Capital City Trust Co. FL, Donaldson Capital Management LLC, Louisiana State Employees Retirement System, and Huntington National Bank. Company insiders that have bought AmerisourceBergen stock in the last two years include Dermot Mark Durcan, and James F Cleary Jr.
View insider buying and selling activity for AmerisourceBergen or or view top insider-buying stocks.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $106.80.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $21.81 billion and generates $189.89 billion in revenue each year. The company earns $-3,408,720,000.00 in net income (profit) each year or $7.90 on an earnings per share basis. AmerisourceBergen employs 22,000 workers across the globe.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]

This page was last updated on 1/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here